Cooke & Bieler LP Has $37.46 Million Holdings in Integer Holdings Corporation (NYSE:ITGR)

Cooke & Bieler LP boosted its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 6.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 317,393 shares of the medical equipment provider's stock after purchasing an additional 18,790 shares during the quarter. Cooke & Bieler LP owned about 0.91% of Integer worth $37,456,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Edgestream Partners L.P. lifted its position in Integer by 208.4% during the first quarter. Edgestream Partners L.P. now owns 36,729 shares of the medical equipment provider's stock valued at $4,334,000 after purchasing an additional 24,819 shares during the period. MQS Management LLC purchased a new stake in shares of Integer in the first quarter worth $272,000. New York State Common Retirement Fund increased its stake in shares of Integer by 7.4% in the first quarter. New York State Common Retirement Fund now owns 249,847 shares of the medical equipment provider's stock worth $29,484,000 after purchasing an additional 17,278 shares in the last quarter. Laurus Global Equity Management Inc. grew its stake in Integer by 16.8% during the first quarter. Laurus Global Equity Management Inc. now owns 47,770 shares of the medical equipment provider's stock valued at $5,637,000 after acquiring an additional 6,855 shares in the last quarter. Finally, Xponance Inc. grew its stake in Integer by 5.1% during the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock valued at $297,000 after acquiring an additional 122 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Insiders Place Their Bets

In related news, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares in the company, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 in the last quarter. 2.16% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ITGR has been the subject of several analyst reports. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and raised their target price for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. KeyCorp lowered their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Finally, Benchmark decreased their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Integer presently has an average rating of "Moderate Buy" and a consensus target price of $146.25.

Integer Stock Performance

Shares of Integer stock traded down $2.13 during trading hours on Friday, reaching $112.51. The company's stock had a trading volume of 463,003 shares, compared to its average volume of 390,078. The stock has a market cap of $3.93 billion, a P/E ratio of 53.32, a price-to-earnings-growth ratio of 0.97 and a beta of 0.98. The company's 50 day simple moving average is $119.65 and its 200 day simple moving average is $124.39. Integer Holdings Corporation has a one year low of $104.93 and a one year high of $146.36. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.95% and a net margin of 4.38%. The business had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same period in the prior year, the business posted $1.14 earnings per share. Integer's revenue was up 7.3% compared to the same quarter last year. As a group, analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.